Patent · US Active

Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals

US9119851B2 · kind B2 · utility

0Cited by

5References

29Claims

0Family size

Assignee

Neuren Pharmaceuticals Limited · NL

Inventors

Michael John Bickerdike · Auckland, NZ
Jian Guan · Shanghai, CN

Key dates

Filing date	Jun 25, 2014
Grant date	Sep 1, 2015
Priority date	—
Expiry date	Jun 25, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of this invention provide methods for therapeutic use of cyclic G-2-Allyl Proline to treat cognitive disorders as well as manufacture of medicaments including tablets, capsules, injectable solutions that are useful for treatment of such conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.